Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type

Wilson, Duncan and Charidimou, Andreas and Shakeshaft, Clare and Ambler, Gareth and White, Mark and Cohen, Hannah and Yousry, Tarek and Al-Shahi Salman, Rustam and Lip, Gregory Y H and Brown, Martin M and Jäger, Hans Rolf and Werring, David J and Emsley, Hedley and , CROMIS-2 collaborators (2016) Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. Neurology, 86 (4). pp. 360-366. ISSN 0028-3878

Full text not available from this repository.

Abstract

OBJECTIVE: To compare intracerebral hemorrhage (ICH) volume and clinical outcome of non-vitamin K oral anticoagulants (NOAC)-associated ICH to warfarin-associated ICH. METHODS: In this multicenter cross-sectional observational study of patients with anticoagulant-associated ICH, consecutive patients with NOAC-ICH were compared to those with warfarin-ICH selected from a population of 344 patients with anticoagulant-associated ICH. ICH volume was measured by an observer blinded to clinical details. Outcome measures were ICH volume and clinical outcome adjusted for confounding factors. RESULTS: We compared 11 patients with NOAC-ICH to 52 patients with warfarin-ICH. The median ICH volume was 2.4 mL (interquartile range [IQR] 0.3-5.4 mL) for NOAC-ICH vs 8.9 mL (IQR 4.0-21.3 mL) for warfarin-ICH (p = 0.0028). In univariate linear regression, use of warfarin (difference in cube root volume 1.61; 95% confidence interval [CI] 0.69 to 2.53) and lobar ICH location (compared with nonlobar ICH; difference in cube root volume 1.52; 95% CI 2.20 to 0.85) were associated with larger ICH volumes. In multivariable linear regression adjusting for confounding factors (sex, hypertension, previous ischemic stroke, white matter disease burden, and premorbid modified Rankin Scale score [mRS]), warfarin use remained independently associated with larger ICH (cube root) volumes (coefficient 0.64; 95% CI 0.24 to 1.25; p = 0.042). Ordered logistic regression showed an increased odds of a worse clinical outcome (as measured by discharge mRS) in warfarin-ICH compared with NOAC-ICH: odds ratio 4.46 (95% CI 1.10 to 18.14; p = 0.037). CONCLUSIONS: In this small prospective observational study, patients with NOAC-associated ICH had smaller ICH volumes and better clinical outcomes compared with warfarin-associated ICH.

Item Type:
Journal Article
Journal or Publication Title:
Neurology
Additional Information:
© 2015 American Academy of Neurology.
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700/2728
Subjects:
ID Code:
84944
Deposited By:
Deposited On:
28 Feb 2017 13:24
Refereed?:
Yes
Published?:
Published
Last Modified:
12 Aug 2020 05:57